MCID: NNT004
MIFTS: 35

Neonatal Respiratory Failure

Categories: Fetal diseases, Respiratory diseases

Aliases & Classifications for Neonatal Respiratory Failure

MalaCards integrated aliases for Neonatal Respiratory Failure:

Name: Neonatal Respiratory Failure 12 14 69
Respiratory Failure of Newborn 12

Classifications:



External Ids:

Disease Ontology 12 DOID:11161
ICD10 33 P28.5
ICD9CM 35 770.84
SNOMED-CT 64 206317005 95619009
UMLS 69 C0521648

Summaries for Neonatal Respiratory Failure

MalaCards based summary : Neonatal Respiratory Failure, also known as respiratory failure of newborn, is related to respiratory failure and tricuspid valve prolapse. An important gene associated with Neonatal Respiratory Failure is ABCA3 (ATP Binding Cassette Subfamily A Member 3), and among its related pathways/superpathways are Diseases of metabolism and Surfactant metabolism. The drugs Nitric Oxide and Benzocaine have been mentioned in the context of this disorder. Affiliated tissues include lung, brain and testes, and related phenotype is respiratory system.

Related Diseases for Neonatal Respiratory Failure

Diseases related to Neonatal Respiratory Failure via text searches within MalaCards or GeneCards Suite gene sharing:

(show all 36)
id Related Disease Score Top Affiliating Genes
1 respiratory failure 10.5
2 tricuspid valve prolapse 10.1 ABCA3 SFTPC
3 tracheoesophageal fistula symphalangism 10.0 SFTPB SFTPD
4 intestinal atresia 10.0 SFTPB SFTPC
5 middle lobe syndrome 9.9 SFTPC SFTPD
6 acute chest syndrome 9.9 SFTPC SFTPD
7 hartnup disorder 9.9 SFTPB SFTPC
8 anonychia with flexural pigmentation 9.8 ABCA3 SFTPB SFTPC
9 anoxia 9.8 ABCA3 SFTPB SFTPC
10 skull base neoplasm 9.8 SFTPB SFTPC
11 osteoarthritis 9.8 ABCA3 SFTPB SFTPC
12 sensorineural hearing loss 9.7
13 coronary stenosis 9.6 SFTPB SFTPC SFTPD
14 neurotrophic keratoconjunctivitis 9.6 SFTPB SFTPC SFTPD
15 adenocarcinoid tumor 9.6 SFTPB SFTPC SFTPD
16 renal oncocytoma 9.6 SFTPC SFTPD
17 interstitial lung disease 9.6
18 lung disease 9.6
19 myotonic dystrophy 9.6
20 alveolar capillary dysplasia 9.6
21 diffuse intrinsic pontine glioma 9.6
22 glioma 9.6
23 rhizomelic chondrodysplasia punctata, type 1 9.6
24 bronchopulmonary dysplasia 9.6
25 congenital hypothyroidism 9.6
26 chlamydia 9.6
27 gestational diabetes 9.6
28 hypothyroidism 9.6
29 rhizomelic chondrodysplasia punctata 9.6
30 anogenital venereal wart 9.6 SFTPB SFTPC SFTPD
31 adenoid squamous cell carcinoma 9.5 SFTPB SFTPC SFTPD
32 radioulnar synostosis with amegakaryocytic thrombocytopenia 9.3 ABCA3 SFTPB SFTPC SFTPD
33 granulomatous orchitis 9.3 ABCA3 SFTPB SFTPC SFTPD
34 bullous skin disease 9.2 ABCA3 SFTPB SFTPC SFTPD
35 diamond-blackfan anemia 3 9.2 ABCA3 SFTPB SFTPC SFTPD
36 common wart 7.8 ABCA3 LMOD3 SFTPB SFTPC SFTPD TRPS1

Graphical network of the top 20 diseases related to Neonatal Respiratory Failure:



Diseases related to Neonatal Respiratory Failure

Symptoms & Phenotypes for Neonatal Respiratory Failure

MGI Mouse Phenotypes related to Neonatal Respiratory Failure:

44
id Description MGI Source Accession Score Top Affiliating Genes
1 respiratory system MP:0005388 9.02 TRPS1 ABCA3 SFTPB SFTPC SFTPD

Drugs & Therapeutics for Neonatal Respiratory Failure

Drugs for Neonatal Respiratory Failure (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 121)
id Name Status Phase Clinical Trials Cas Number PubChem Id
1
Nitric Oxide Approved Phase 4,Phase 3,Phase 2,Phase 1 10102-43-9 145068
2
Benzocaine Approved Phase 4,Phase 3,Phase 2,Phase 1 1994-09-7, 94-09-7 2337
3 Beractant Approved Phase 4,Phase 3 108778-82-1
4 Poractant alfa Approved Phase 4,Phase 2 129069-19-8
5
Morphine Approved, Investigational Phase 4 57-27-2 5288826
6
Atropine Approved, Vet_approved Phase 4 5908-99-6, 51-55-8 174174
7
Adenosine Approved, Investigational Phase 4 58-61-7 60961
8
Remifentanil Approved Phase 4,Phase 2 132875-61-7 60815
9 tannic acid Approved, Nutraceutical Phase 4,Phase 3,Phase 2,Phase 1
10 Analgesics Phase 4,Phase 3,Phase 2
11 Respiratory System Agents Phase 4,Phase 3,Phase 2,Phase 1
12 Central Nervous System Depressants Phase 4,Phase 3,Phase 2
13 Neurotransmitter Agents Phase 4,Phase 3,Phase 2,Phase 1
14 Vasodilator Agents Phase 4,Phase 3,Phase 2,Phase 1
15 Peripheral Nervous System Agents Phase 4,Phase 3,Phase 2,Phase 1
16 Hypnotics and Sedatives Phase 4,Phase 3,Phase 2
17 Protective Agents Phase 4,Phase 3,Phase 2,Phase 1
18 Pulmonary Surfactants Phase 4,Phase 3,Phase 2
19 Autonomic Agents Phase 4,Phase 3,Phase 2,Phase 1
20 Adjuvants, Anesthesia Phase 4
21 Cholinergic Agents Phase 4
22 Muscarinic Antagonists Phase 4
23 Cholinergic Antagonists Phase 4
24 Mydriatics Phase 4
25 Narcotics Phase 4,Phase 2
26 Analgesics, Opioid Phase 4,Phase 2
27 Anesthetics Phase 4,Phase 2
28 Anesthetics, General Phase 4,Phase 2
29 Anesthetics, Intravenous Phase 4,Phase 2
30 Parasympatholytics Phase 4
31 Anti-Arrhythmia Agents Phase 4
32 Anti-Asthmatic Agents Phase 4,Phase 3,Phase 2,Phase 1
33 Endothelium-Dependent Relaxing Factors Phase 4,Phase 3,Phase 2,Phase 1
34 Bronchodilator Agents Phase 4,Phase 3,Phase 2,Phase 1
35 Antioxidants Phase 4,Phase 3,Phase 2,Phase 1
36 Mitogens Phase 4
37 Endothelial Growth Factors Phase 4
38
Dexmedetomidine Approved, Vet_approved Phase 3,Phase 2 76631-46-4, 113775-47-6 68602 5311068 56032
39
Dexamethasone Approved, Investigational, Vet_approved Phase 3 50-02-2 5743
40
Calfactant Approved Phase 3 183325-78-2
41 Sildenafil Citrate Phase 3,Phase 2 171599-83-0
42 glucocorticoids Phase 3,Phase 2
43 Adrenergic Agents Phase 3,Phase 2
44 Adrenergic Agonists Phase 3,Phase 2
45 Adrenergic alpha-2 Receptor Agonists Phase 3,Phase 2
46 Adrenergic alpha-Agonists Phase 3,Phase 2
47 Gastrointestinal Agents Phase 3,Phase 2
48 Analgesics, Non-Narcotic Phase 3,Phase 2
49 Hormone Antagonists Phase 3,Phase 2
50 Hormones Phase 3,Phase 2

Interventional clinical trials:

(show top 50) (show all 148)

id Name Status NCT ID Phase Drugs
1 Brain Oxygenation and Function of Preterm Newborns During Administration of Two Different Surfactant Preparations Unknown status NCT01941524 Phase 4 Poractant alfa instillation;Beractant instillation
2 Comparison of Nasal CPAP and Nasal SIMV in Transient Tachypnea of Newborn Unknown status NCT01499238 Phase 4
3 Inhaled Nitric Oxide by Oxygen Hood in Neonates Completed NCT00732537 Phase 4 inhaled Nitric Oxide;Oxygen (>90% by hood) - standard therapy
4 Follow-Up at 6 Years of a Cohort of Children Born Very Prematurely Completed NCT00390065 Phase 4 Nitric Oxide
5 Lung Lavage With Dilute Poractant Alfa for Meconium Aspiration Syndrome Completed NCT02041546 Phase 4 Lung lavage with surfactant;Bolus surfactant
6 Randomized Controlled Trial of Surfactant Delivery Via Laryngeal Mask Airway (LMA) Versus Endotracheal Intubation Completed NCT01042600 Phase 4
7 Standard Treatment Compliance of Participants, Effectiveness and Prognosis in Acute Respiratory Distress Syndrome Completed NCT02178982 Phase 4
8 Early iNO for Oxidative Stress, Vascular Tone and Inflammation in Babies With Hypoxic Respiratory Failure Recruiting NCT01891500 Phase 4 Inhaled nitric oxide;Nitrogen Gas;Crossover iNO
9 Surfactant Via Endotracheal Tube vs. Laryngeal Mask Airway (LMA) in Preterm Neonates With Respiratory Distress Syndrome Recruiting NCT02164734 Phase 4 remifentanil
10 Effect of Non-Invasive Ventilation in Cystic Fibrosis Patient With Chronic Respiratory Failure. Terminated NCT00208078 Phase 4
11 A Study of Bi-Level Positive Airway Pressure (BIPAP) Versus Non Invasive Positive Pressure Ventilation (NIPPV) for Neonatal Respiratory Failure Unknown status NCT01318824 Phase 3
12 Use of Orotracheal Continuous Positive Airway Pressure (CPAP) in Newborns With Respiratory Failure Unknown status NCT01379820 Phase 2, Phase 3
13 Non Invasive Ventilation Versus Continuous Positive Airway Pressure After Extubation of Very Low Birth Weight Infants. Unknown status NCT01778829 Phase 3
14 Dexmedetomidine in Mechanically Ventilated Neonates With Single-Organ Respiratory Failure. Unknown status NCT01266252 Phase 3 Dexmedetomidine
15 Sildenofil in Persistent Pulmonary Hypertension in Newborns Unknown status NCT01558466 Phase 3 Sildenafil;diluent
16 Sedation Management in Pediatric Patients With Acute Respiratory Failure (The RESTORE Study) Completed NCT00814099 Phase 3
17 Prolonged Outcomes After Nitric Oxide (PrONOx) Completed NCT00234247 Phase 3
18 Study of a Novel Technique of Mechanical Ventilation in Patients With Severe Acute Respiratory Failure Completed NCT00637507 Phase 2, Phase 3
19 Inhaled Nitric Oxide to Prevent and Treat Bronchopulmonary Dysplasia Completed NCT01503801 Phase 2, Phase 3 Nitric Oxide
20 Dexamethasone Therapy in VLBW Infants at Risk of CLD Completed NCT00011362 Phase 3 Dexamethasone Early;Dexamethasone Late
21 Prone-Supine Study II: The Effect of Prone Positioning for Patients Affected by Acute Respiratory Distress Syndrome Completed NCT00159939 Phase 3
22 A Study To Evaluate Safety And Efficacy Of IV Sildenafil In The Treatment Of Neonates With Persistent Pulmonary Hypertension Of The Newborn Recruiting NCT01720524 Phase 3 placebo;iv sildenafil
23 Safety And Efficacy Of Dexmedetomidine Sedation In Intubated Mechanically Ventilated Infants With Respiratory Failure Recruiting NCT02996058 Phase 2, Phase 3 Dexmedetomidine 0.35µg/kg /h;Dexmedetomidine 0.5µg/kg /h
24 Inhaled Nitric Oxide Study for Respiratory Failure in Newborns Terminated NCT00005776 Phase 3 Inhaled nitric oxide;Placebo
25 Early Inhaled Nitric Oxide for Respiratory Failure in Newborns Terminated NCT00005773 Phase 3 Inhaled Nitric Oxide;Standard iNO therapy
26 Inhaled Nitric Oxide for Preterm Infants With Severe Respiratory Failure Terminated NCT00016523 Phase 3 Inhaled nitric oxide;Placebo
27 Early Surfactant to Reduce Use of Mechanical Breathing in Low Birth Weight Infants Terminated NCT00005774 Phase 3 Early surfactant;Standard practice
28 Calfactant for Direct Acute Respiratory Distress Syndrome Terminated NCT00682500 Phase 3 Calfactant;Room Air (placebo)
29 Minimal Breathing Support and Early Steroids to Prevent Chronic Lung Disease in Extremely Premature Infants (SAVE) Terminated NCT00005777 Phase 3 Dexamethasone;Placebo
30 Comparative Evaluation of Albumin and Starch Effects in Acute Lung Injury (ALI) Terminated NCT00796419 Phase 3 5% human albumin;6% hetastarch
31 Use of the Hattler Respiratory Assist Catheter in Severe Respiratory Failure Withdrawn NCT00288964 Phase 3
32 Airway Pressure Release Ventilation (APRV) Versus AC/VC Conventional Ventilation Unknown status NCT01339533 Phase 2
33 Use of the Medical Device DECAP CO2 for the Treatment of Hypercapnic Respiratory Distress in Patients Under Noninvasive Ventilation Unknown status NCT01774422 Phase 2
34 Strategies to Optimize Positive End-expiratory Pressure (PEEP) in Patients With Acute Lung Injury Unknown status NCT01326208 Phase 2
35 Trial of Steroids in Pediatric Acute Lung Injury/ARDS Unknown status NCT01274260 Phase 2 methylprednisolone;Normal Saline (0.9%)
36 Study of Ganciclovir/Valganciclovir for Prevention of Cytomegalovirus Reactivation in Acute Injury of the Lung and Respiratory Failure Completed NCT01335932 Phase 2 IV Ganciclovir;Placebo
37 Dexmedetomidine vs. Remifentanil for Pre-eclampsia During Caesarean Delivery Completed NCT01766089 Phase 2 Remifentanil;Dexmedetomidine
38 Ventilatory Management of the Preterm Neonate in the Delivery Room Completed NCT01255826 Phase 2
39 Comparison of Two Methods of High Frequency Oscillatory Ventilation in Individuals With Acute Respiratory Distress Syndrome Completed NCT00399581 Phase 2
40 Early Insulin and Development of ARDS Completed NCT00605696 Phase 2 Insulin
41 A Study To InvestigateThe Safety, Tolerability And Efficacy Of Nebulised Curosurf® In Preterm Neonates With Respiratory Distress Syndrome (RDS) Recruiting NCT03235986 Phase 2 nCPAP (nasal Continuous Positive Airway Pressure) + Nebulised Curosurf® (Part I);nCPAP (nasal Continuous Positive Airway Pressure) + Nebulised Curosurf® (Part II)
42 Trial to Assess the Safety and Efficacy of Lucinactant for Inhalation in Premature Neonates 26 to 32 Weeks Gestational Age Recruiting NCT02636868 Phase 2 Lucinactant delivered via investigational delivery device;nCPAP
43 Milrinone in Congenital Diaphragmatic Hernia Recruiting NCT02951130 Phase 2 Milrinone;Placebo (5% Dextrose)
44 PEEP and V/Q Mismatch in Premature Infants Recruiting NCT03109613 Phase 1, Phase 2
45 Mesenchymal Stem Cell in Patients With Acute Severe Respiratory Failure Recruiting NCT02112500 Phase 2
46 Treprostinil Sodium Inhalation for Patients At High Risk for ARDS Recruiting NCT02370095 Phase 2 Treprostinil Inhalation Solution;Placebo
47 Inhaled Prostaglandin E1 (IPGE1) for Hypoxemic Respiratory Failure (NHRF) Terminated NCT01467076 Phase 2 Aerosolized Normal Saline;Inhaled PGE1
48 Study of Sildenafil to Treat Newborns With Persistent Pulmonary Hypertension Terminated NCT01409031 Phase 2 Intravenous Sildenafil
49 Study To Investigate Safety And Efficacy Of Sildenafil In The Newborns With Persistent Pulmonary Hypertension (PPHN) Terminated NCT01069861 Phase 2 sildanefil
50 Inhaled PGE1 in Neonatal Hypoxemic Respiratory Failure Withdrawn NCT00598429 Phase 2 Inhaled Prostaglandin E1

Search NIH Clinical Center for Neonatal Respiratory Failure

Genetic Tests for Neonatal Respiratory Failure

Anatomical Context for Neonatal Respiratory Failure

MalaCards organs/tissues related to Neonatal Respiratory Failure:

39
Lung, Brain, Testes, Endothelial, Kidney

Publications for Neonatal Respiratory Failure

Articles related to Neonatal Respiratory Failure:

(show top 50) (show all 81)
id Title Authors Year
1
Lung Rest During Extracorporeal Membrane Oxygenation for Neonatal Respiratory Failure-Practice Variations and Outcomes. ( 28504997 )
2017
2
The most frequent ABCA3 nonsense mutation -p.Tyr1515* (Y1515X) causing lethal neonatal respiratory failure in a term neonate. ( 28808495 )
2017
3
Neonatal Respiratory Failure Caused by Congenital Diffuse Intrinsic Pontine Glioma. ( 28116951 )
2017
4
Neonatal respiratory failure due to ABCA3 deficiency. ( 28038995 )
2016
5
Mortality of Neonatal Respiratory Failure from Chinese Northwest NICU Network. ( 27651118 )
2016
6
Venoarterial extracorporeal life support for neonatal respiratory failure: indications and impact on mortality. ( 27984316 )
2016
7
Neonatal Respiratory Failure with Retarded Perinatal Lung Maturation in Mice Caused by Reticulocalbin 3 Disruption. ( 26252542 )
2015
8
Effect of Change of Mechanical Ventilation Position on the Treatment of Neonatal Respiratory Failure. ( 25647746 )
2015
9
Successful primary use of VVDL+V ECMO with cephalic drain in neonatal respiratory failure. ( 26562372 )
2015
10
Exercise capacity, daily activity, and severity of fatigue in term born young adults after neonatal respiratory failure. ( 22724460 )
2014
11
Venoarterial versus venovenous ECMO for neonatal respiratory failure. ( 24580762 )
2014
12
Successful treatment of neonatal respiratory failure caused by a novel surfactant protein C p.Cys121Gly mutation with hydroxychloroquine. ( 23719253 )
2013
13
Comparison of High Frequency Positive Pressure Mechanical Ventilation (HFPPV) With Conventional Method in the Treatment of Neonatal Respiratory Failure. ( 23983995 )
2013
14
Morbidity and mortality of neonatal respiratory failure in China: surfactant treatment in very immature infants. ( 22331337 )
2012
15
The pulmonary circulation in neonatal respiratory failure. ( 22954275 )
2012
16
Rhizomelic chondrodysplasia punctata type 1 and fulminant neonatal respiratory failure, a case report and discussion of pathophysiology. ( 22052861 )
2011
17
Gestational diabetes: a strong independent risk factor for severe neonatal respiratory failure after 34 weeks. ( 21170541 )
2011
18
Acute management of neonatal respiratory failure due to crossed ectopic obstructed megaureter in a duplicated pelvic kidney. ( 21050823 )
2011
19
Fatal neonatal respiratory failure in an infant with congenital hypothyroidism due to haploinsufficiency of the NKX2-1 gene: alteration of pulmonary surfactant homeostasis. ( 20584796 )
2011
20
Mortality of neonatal respiratory failure related to socioeconomic factors in Hebei province of China. ( 21150226 )
2011
21
Extracorporeal membrane oxygenation and term neonatal respiratory failure deaths in the United Kingdom compared with the United States: 1999 to 2005. ( 19593243 )
2010
22
Neonatal respiratory failure due to a novel mutation in the surfactant protein C gene. ( 20118944 )
2010
23
Extracorporeal membrane oxygenation for the treatment of neonatal respiratory failure. ( 19713207 )
2009
24
Extracorporeal membrane oxygenation for neonatal respiratory failure. ( 19712500 )
2009
25
Neonatal respiratory failure: a 12-month clinical epidemiologic study from 2004 to 2005 in China. ( 18450855 )
2008
26
Clinical correlations and pulmonary function at 8 years of age after severe neonatal respiratory failure. ( 17654569 )
2007
27
Ototoxic drugs and sensorineural hearing loss following severe neonatal respiratory failure. ( 16449030 )
2006
28
ABCA3 deficiency: neonatal respiratory failure and interstitial lung disease. ( 17142158 )
2006
29
Neonatal respiratory failure associated with mutation in the surfactant protein C gene. ( 16355106 )
2006
30
Continuous negative extrathoracic pressure (CNEP) in neonatal respiratory failure: correction. ( 16740893 )
2006
31
ECMO for neonatal respiratory failure. ( 15921148 )
2005
32
[Neonatal respiratory failure associated with mutation in the surfactant protein C gene]. ( 15737281 )
2005
33
Venovenous extracorporeal membrane oxygenation in neonatal respiratory failure: does routine, cephalad jugular drainage improve outcome? ( 15136997 )
2004
34
Acinar dysplasia: a rare cause of neonatal respiratory failure. ( 15174801 )
2004
35
Long-term pulmonary sequelae in children who were treated with extracorporeal membrane oxygenation for neonatal respiratory failure. ( 15520110 )
2004
36
Cost-effectiveness of inhaled nitric oxide in the treatment of neonatal respiratory failure in the United States. ( 14654609 )
2003
37
Cost-effectiveness of inhaled nitric oxide in the treatment of neonatal respiratory failure in the US. ( 14654622 )
2003
38
Neonatal respiratory failure. ( 12011671 )
2002
39
Late-onset, progressive sensorineural hearing loss after severe neonatal respiratory failure. ( 11981395 )
2002
40
Acute neonatal respiratory failure and Chlamydia trachomatis. ( 11287694 )
2001
41
Epidemiology of neonatal respiratory failure in the United States: projections from California and New York. ( 11673202 )
2001
42
State of the art. Neonatal respiratory failure. ( 10855113 )
1999
43
Intratracheal pulmonary ventilation in neonatal respiratory failure. ( 9934880 )
1999
44
Experimental neonatal respiratory failure induced by lysophosphatidylcholine: effect of surfactant treatment. ( 9931201 )
1999
45
Alveolar capillary dysplasia with misalignment of the pulmonary veins: a rare but fatal cause of neonatal respiratory failure. ( 9880707 )
1998
46
Which interventions for neonatal respiratory failure are effective? ( 9575272 )
1998
47
Early measurement of lung volume--a useful discriminator of neonatal respiratory failure severity. ( 8746375 )
1996
48
Continuous negative extrathoracic pressure in neonatal respiratory failure. ( 8951269 )
1996
49
Clinical approaches to the use of high-frequency oscillatory ventilation in neonatal respiratory failure. ( 8732550 )
1996
50
A comparison of venovenous and venoarterial extracorporeal membrane oxygenation in the treatment of neonatal respiratory failure. ( 8874305 )
1996

Variations for Neonatal Respiratory Failure

Expression for Neonatal Respiratory Failure

Search GEO for disease gene expression data for Neonatal Respiratory Failure.

GO Terms for Neonatal Respiratory Failure

Cellular components related to Neonatal Respiratory Failure according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 extracellular space GO:0005615 9.62 ABCA3 SFTPB SFTPC SFTPD
2 multivesicular body lumen GO:0097486 9.26 SFTPB SFTPC
3 alveolar lamellar body GO:0097208 9.16 ABCA3 SFTPB
4 clathrin-coated endocytic vesicle GO:0045334 9.13 SFTPB SFTPC SFTPD
5 lamellar body GO:0042599 8.8 SFTPB SFTPC SFTPD

Biological processes related to Neonatal Respiratory Failure according to GeneCards Suite gene sharing:

id Name GO ID Score Top Affiliating Genes
1 cellular protein metabolic process GO:0044267 9.26 ABCA3 SFTPB SFTPC SFTPD
2 respiratory gaseous exchange GO:0007585 8.8 SFTPB SFTPC SFTPD

Sources for Neonatal Respiratory Failure

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 MedGen
42 MeSH
43 MESH via Orphanet
44 MGI
46 NCI
47 NCIt
48 NDF-RT
51 NINDS
52 Novoseek
54 OMIM
55 OMIM via Orphanet
59 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....